Insights has moved to a new home on Substack!
This week, we are focusing on China and the abundance of sanctions and new regulations we project are on the horizon, and we have published a new advisory flagging the risks US firms and financial institutions face when transacting with entities in the pharmaceutical industry in China.
But there is so much more happening!
From Russian billionaires who are likely funding private military companies to supplement Russia’s war in Ukraine, to expanded EU sanctions targeting Russian disinformation, to millions of dollars in fraud, to developments in the crypto space, we help you make sense of it all.
Click below, and don’t forget to subscribe!